Genomics: saviour or millstone? [Trends Genet. 2001] - PubMed Result

SearchDatabase nameforSearch term

Advanced Search

Your browser version may not work well with NCBI's Web applications. More information here...

Display Show

All: 1

Review: 0

Click to change filter selection through MyNCBI.

1: Trends Genet. 2001 May;17(5):247-8. Links

Genomics: saviour or millstone?

Ceros Ltd, Wellington House, Cambridge, UK. sohaila@rastan.fsnet.co.uk

The Keystone Symposium on the impact of Genomics Development was held in Santa Fe, New Mexico, from 2 to 7 February 2001.

PMID: 11426417 [PubMed - indexed for MEDLINE]

Related articles

Retrospective validation of genomic biomarkers-- what are the questions, challenges and strategies for developing useful relationships to clinical outcomes-- workshop summary.
Pharmacogenomics J. 2006 Mar-Apr; 6(2):82-8.

[Pharmacogenomics J. 2006]
Pushing drugs: genomics and genetics, the pharmaceutical industry, and the law of negligence.
Washburn Law J. 2003 Spring; 42(3):575-99.

[Washburn Law J. 2003]
An individual approach.
Nature. 2005 Aug 4; 436(7051):746-7.

[Nature. 2005]
Biotech industry tries to recover from 2-year lull.
J Natl Cancer Inst. 2003 Mar 5; 95(5):348-9.

[J Natl Cancer Inst. 2003]
Review[Development of antituberculous drugs: current status and future prospects]
Kekkaku. 2006 Dec; 81(12):753-74.

[Kekkaku. 2006]
» See reviews... | » See all...

Recent Activity

Clear Turn Off Turn On

Genomics: saviour or millstone?Genomics: saviour or millstone?

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Display Show